Judges Scientific (LSE:JDG) entered the pandemic in good shape, having achieved record revenue, cash flow, profit and new orders in the year to December 2019. Despite paying a special dividend and a modest acquisition just before the year end, it finished the year with little debt and declared a “robust ability to take advantage of opportunities as they arise.”